BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Stallergenes, S.A. 

6, Rue Alexis de Tocqueville

Antony  Cedex  92183  France
Phone: 33-1-55-59-20-00 Fax: 33-1-55-59-21-68


SEARCH JOBS




Industry
Biotechnology






 Company News
Stallergenes, S.A. (GENP.PA) Expands Latin American Presence With Acquisition Of Alergo Pharma S.R.L. In Argentina 7/21/2014 12:30:34 PM
Stallergenes, S.A. (GENP.PA) Wins FDA's Go-Ahead For Oralair Allergy Pill 4/2/2014 7:36:14 AM
FDA Advisory Committee Supports Approval Of Stallergenes, S.A. (GENP.PA)'s ORALAIR(R) For The Treatment Of Grass Pollen Allergy 12/12/2013 7:10:02 AM
Greer Labs and Stallergenes, S.A. (GENP.PA) Sign Exclusive Agreement for United States Commercialization Rights to Oralair® 10/31/2013 12:30:46 PM
Greer Labs and Stallergenes, S.A. (GENP.PA) Sign Exclusive Agreement for United States Commercialization Rights to Oralair® 10/31/2013 12:24:36 PM
Stallergenes, S.A. (GENP.PA) Inks $198 Million Pact for Allergy R&D With DBV Technologies 10/18/2013 10:12:37 AM
DBV Technologies and Stallergenes, S.A. (GENP.PA) Enter Into Partnership for the Development of Innovative Treatment of Respiratory Allergies 5/17/2013 10:25:44 AM
Aerocrine and Stallergenes, S.A. (GENP.PA) Sign Exclusive Distribution Agreement for NIOX MINO® 8/28/2012 9:47:52 AM
Stallergenes, S.A. (GENP.PA) Release: 1st Half-Year 2012: Sales Up 6% Solid Performance in a Sensitive Economic Situation 7/12/2012 11:49:13 AM
Ares Life SciencesHolds 73.18% of the Capital and Voting Rights of Stallergenes, S.A. (GENP.PA) At the End of the Offering Period 3/17/2011 11:13:57 AM
12345